Castillo-Tokumori Franco, Irey-Salgado Claudia, Málaga Germán
CONEVID, Unidad de Conocimiento y Evidencia, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Urb. Ingeniería, San Martín de Porres, Lima, Peru.
CONEVID, Unidad de Conocimiento y Evidencia, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Urb. Ingeniería, San Martín de Porres, Lima, Peru; Departamento de Medicina, Hospital Cayetano Heredia, San Martín de Porres, Lima, Peru.
Int J Infect Dis. 2017 Feb;55:16-19. doi: 10.1016/j.ijid.2016.12.007. Epub 2016 Dec 12.
There has been a sustained and dramatic increase in community-acquired urinary tract infections (CA-UTI) caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria over recent years. Despite this, no studies have been performed in low- or middle-income countries. The main objective of this case-control study was to describe ESBL CA-UTI and its risk factors.
Outpatients with CA-UTI seen at the Hospital Cayetano Heredia during 2015 were identified. Patients were contacted by telephone. After consent had been obtained, a questionnaire concerning previously identified risk factors was applied. Univariate and multivariate analyses were conducted using Stata version 13.
The overall frequency of ESBL-producing Escherichia coli was 40.85%. Sixty-seven cases and 105 controls were included in this study. The following main risk factors were identified on multivariate analysis: previous antibiotic use (odds ratio (OR) 3.09), previous hospitalization (OR 2.92), and previous surgery (OR 2.75). Chronic corticosteroid use (OR 24.32, 95% confidence interval 2.39-246.92) was also identified as a risk factor.
ESBL E. coli accounted for more than 40% of CA-UTIs during 2015. A history of previous hospitalization, surgery, and antibiotic use should be considered when treating this type of infection. Action should be taken to confirm these worrisome results and avoid the major consequences for public health.
近年来,由产超广谱β-内酰胺酶(ESBL)细菌引起的社区获得性尿路感染(CA-UTI)持续急剧增加。尽管如此,低收入或中等收入国家尚未开展相关研究。本病例对照研究的主要目的是描述产ESBL的CA-UTI及其危险因素。
确定2015年在卡耶塔诺·埃雷迪亚医院就诊的CA-UTI门诊患者。通过电话联系患者。在获得同意后,应用一份关于先前确定的危险因素的问卷。使用Stata 13版本进行单变量和多变量分析。
产ESBL的大肠杆菌总体发生率为40.85%。本研究纳入了67例病例和105例对照。多变量分析确定了以下主要危险因素:既往使用抗生素(比值比(OR)3.09)、既往住院(OR 2.92)和既往手术(OR 2.75)。长期使用皮质类固醇(OR 24.32,95%置信区间2.39 - 246.92)也被确定为危险因素。
2015年期间,产ESBL的大肠杆菌占CA-UTI的40%以上。治疗这类感染时应考虑既往住院、手术和使用抗生素的病史。应采取行动确认这些令人担忧的结果,并避免对公共卫生造成重大后果。